NCT05549609 - A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Venous Leg Ulcer

Interventions

BIOLOGICAL

XSTEM-VLU

XSTEM-VLU is an allogeneic, adipose tissue-derived, integrin alpha10beta1-selected and expanded mesenchymal stem cell (MSC) product for the treatment of venous leg ulcers.

OTHER

Vehicle

CryoStor CS10 cryomedium

Trial Locations (4)

SE-413 46

RECRUITING

Clinical Trial Center (CTC), Gothenburg

SE-581 85

WITHDRAWN

Burn Centre, Linköping University Hospital, Linköping

SE-221 85

WITHDRAWN

Clinical Research Unit, Lund

SE-171 64

RECRUITING

Clinical Trial Consultants (CTC) Karolinska, Stockholm

All Listed Sponsors

collaborator

Vinnova

OTHER_GOV

lead

Xintela AB

INDUSTRY